190 related articles for article (PubMed ID: 16049321)
1. Alcohol-induced myocardial fibrosis in metallothionein-null mice: prevention by zinc supplementation.
Wang L; Zhou Z; Saari JT; Kang YJ
Am J Pathol; 2005 Aug; 167(2):337-44. PubMed ID: 16049321
[TBL] [Abstract][Full Text] [Related]
2. A murine model of alcoholic cardiomyopathy: a role for zinc and metallothionein in fibrosis.
Jones WK
Am J Pathol; 2005 Aug; 167(2):301-4. PubMed ID: 16049317
[No Abstract] [Full Text] [Related]
3. Zinc supplementation prevents alcoholic liver injury in mice through attenuation of oxidative stress.
Zhou Z; Wang L; Song Z; Saari JT; McClain CJ; Kang YJ
Am J Pathol; 2005 Jun; 166(6):1681-90. PubMed ID: 15920153
[TBL] [Abstract][Full Text] [Related]
4. Changes in copper and zinc status and response to dietary copper deficiency in metallothionein-overexpressing transgenic mouse heart.
Kang YJ; Jiang Y; Saari JT
J Nutr Biochem; 2007 Nov; 18(11):714-8. PubMed ID: 17707633
[TBL] [Abstract][Full Text] [Related]
5. Metallothionein Is Downstream of Nrf2 and Partially Mediates Sulforaphane Prevention of Diabetic Cardiomyopathy.
Gu J; Cheng Y; Wu H; Kong L; Wang S; Xu Z; Zhang Z; Tan Y; Keller BB; Zhou H; Wang Y; Xu Z; Cai L
Diabetes; 2017 Feb; 66(2):529-542. PubMed ID: 27903744
[TBL] [Abstract][Full Text] [Related]
6. Metallothionein-independent zinc protection from alcoholic liver injury.
Zhou Z; Sun X; Lambert JC; Saari JT; Kang YJ
Am J Pathol; 2002 Jun; 160(6):2267-74. PubMed ID: 12057929
[TBL] [Abstract][Full Text] [Related]
7. Metallothionein gene therapy for chemical-induced liver fibrosis in mice.
Jiang Y; Kang YJ
Mol Ther; 2004 Dec; 10(6):1130-9. PubMed ID: 15564144
[TBL] [Abstract][Full Text] [Related]
8. Preservation of intestinal structural integrity by zinc is independent of metallothionein in alcohol-intoxicated mice.
Lambert JC; Zhou Z; Wang L; Song Z; McClain CJ; Kang YJ
Am J Pathol; 2004 Jun; 164(6):1959-66. PubMed ID: 15161632
[TBL] [Abstract][Full Text] [Related]
9. Cardiac metallothionein induction plays the major role in the prevention of diabetic cardiomyopathy by zinc supplementation.
Wang J; Song Y; Elsherif L; Song Z; Zhou G; Prabhu SD; Saari JT; Cai L
Circulation; 2006 Jan; 113(4):544-54. PubMed ID: 16432057
[TBL] [Abstract][Full Text] [Related]
10. Metallothionein suppresses angiotensin II-induced nicotinamide adenine dinucleotide phosphate oxidase activation, nitrosative stress, apoptosis, and pathological remodeling in the diabetic heart.
Zhou G; Li X; Hein DW; Xiang X; Marshall JP; Prabhu SD; Cai L
J Am Coll Cardiol; 2008 Aug; 52(8):655-66. PubMed ID: 18702970
[TBL] [Abstract][Full Text] [Related]
11. Metallothionein protects against doxorubicin-induced cardiomyopathy through inhibition of superoxide generation and related nitrosative impairment.
Shuai Y; Guo JB; Peng SQ; Zhang LS; Guo J; Han G; Dong YS
Toxicol Lett; 2007 Apr; 170(1):66-74. PubMed ID: 17382496
[TBL] [Abstract][Full Text] [Related]
12. Zinc rescue of Akt2 gene deletion-linked murine cardiac dysfunction and pathological changes is metallothionein-dependent.
Sun W; Miao X; Zhou S; Zhang L; Epstein PN; Mellen N; Zheng Y; Fu Y; Wang Y; Cai L
J Mol Cell Cardiol; 2014 Sep; 74():88-97. PubMed ID: 24819347
[TBL] [Abstract][Full Text] [Related]
13. Metallothionein prevents cardiac pathological changes in diabetes by modulating nitration and inactivation of cardiac ATP synthase.
Cong W; Zhao T; Zhu Z; Huang B; Ma W; Wang Y; Tan Y; Chakrabarti S; Li X; Jin L; Cai L
J Nutr Biochem; 2014 Apr; 25(4):463-74. PubMed ID: 24629910
[TBL] [Abstract][Full Text] [Related]
14. The embryolethality of lipopolysaccharide in CD-1 and metallothionein I-II null mice: lack of a role for induced zinc deficiency or metallothionein induction.
Leazer TM; Daston GP; Keen CL; Rogers JM
Toxicol Sci; 2003 Jun; 73(2):442-7. PubMed ID: 12700403
[TBL] [Abstract][Full Text] [Related]
15. Expression of the mouse metallothionein-I and -II genes provides a reproductive advantage during maternal dietary zinc deficiency.
Andrews GK; Geiser J
J Nutr; 1999 Sep; 129(9):1643-8. PubMed ID: 10460198
[TBL] [Abstract][Full Text] [Related]
16. Zinc and alcoholic liver disease.
Zhou Z
Dig Dis; 2010; 28(6):745-50. PubMed ID: 21525759
[TBL] [Abstract][Full Text] [Related]
17. Attenuation by metallothionein of early cardiac cell death via suppression of mitochondrial oxidative stress results in a prevention of diabetic cardiomyopathy.
Cai L; Wang Y; Zhou G; Chen T; Song Y; Li X; Kang YJ
J Am Coll Cardiol; 2006 Oct; 48(8):1688-97. PubMed ID: 17045908
[TBL] [Abstract][Full Text] [Related]
18. Diabetic cardiomyopathy and its prevention by metallothionein: experimental evidence, possible mechanisms and clinical implications.
Cai L
Curr Med Chem; 2007; 14(20):2193-203. PubMed ID: 17691957
[TBL] [Abstract][Full Text] [Related]
19. Myocardial oxidative stress and toxicity induced by acute ethanol exposure in mice.
Kannan M; Wang L; Kang YJ
Exp Biol Med (Maywood); 2004 Jun; 229(6):553-9. PubMed ID: 15169975
[TBL] [Abstract][Full Text] [Related]
20. Zinc Supplementation Prevented Type 2 Diabetes-Induced Liver Injury Mediated by the Nrf2-MT Antioxidative Pathway.
Yu L; Liu Y; Jin Y; Liu T; Wang W; Lu X; Zhang C
J Diabetes Res; 2021; 2021():6662418. PubMed ID: 34307690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
